Shanghai New World Co., Ltd

600628

CNE0000006X1

Pharmaceuticals

End-of-day quote Shanghai S.E. Other stock markets 03:30:00 07/06/2024 am IST			5-day change	1st Jan Change
5.79 ^CNY	+2.30%		-3.98%	-17.40%

29/04	Shanghai New World Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
12/04	Shanghai New World Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Shanghai New World Co., Ltd. Provides Earnings Guidance for the First Half of 2015

July 17, 2015

Shanghai New World Co. Ltd. provided earnings guidance for the first half of 2015. The company predicts that its net profit belonging to shareholders of the listed company in 2015 will decrease by 65% to 75% compared with the RMB 13,297.54 in the same period of the year before.

Latest news about Shanghai New World Co., Ltd

Shanghai New World Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024	29/04	CI
Shanghai New World Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2023	12/04	CI
Shanghai New World Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023	30/23/30	CI
Shanghai New World Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2023	30/23/30	CI
Shanghai New World Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023	28/23/28	CI
Shanghai New World Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2022	12/23/12	CI
Shanghai New World Co., Ltd completed the acquisition of 6.1245% of stake in Zhejiang Guojun Co., Ltd. from Shen Guojun and Shen Junyan	07/23/07	CI
Shanghai New World Co., Ltd agreed to acquire 6.1245% of stake in Zhejiang Guojun Co., Ltd. from Shen Guojun and Shen Junyan for approximately CNY 490 million.	18/23/18	CI
Shanghai New World Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2022	27/22/27	CI
Shanghai New World Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2022	30/22/30	CI
Shanghai New World Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2022	30/22/30	CI
Shanghai New World Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2021	28/21/28	CI
Shanghai New World Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2021	26/21/26	CI
Shanghai Cai Tongde Pharmaceutical Co., Ltd. announced that it has received CNY 20 million in funding from Shanghai New World Co., Ltd	18/21/18	CI
Shanghai New World Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2021	30/21/30	CI
Shanghai New World Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2020	14/21/14	CI
Shanghai Cai Tongde Pharmaceutical Co., Ltd. announced that it expects to receive CNY 20 million in funding from Shanghai New World Co., Ltd	18/21/18	CI
Shanghai New World Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2020	29/20/29	CI
Shanghai New World Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2020	27/20/27	CI
Shanghai New World Co., Ltd Announces Cash Dividend on A Share for the Year 2019, Payable on August 21, 2020	16/20/16	CI
Shanghai New World Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2020	29/20/29	CI
Shanghai New World Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2019	16/20/16	CI
Shanghai New World Co., Ltd Announces Earnings Guidance for 2019	21/20/21	CI
Shanghai New World Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2019	30/19/30	CI
Shanghai New World Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2019	28/19/28	CI

Chart Shanghai New World Co., Ltd

Duration

Period

More charts

Company Profile

Shanghai New World Co Ltd is a China-based company mainly engaged in department store retail enterprises integrating modern department stores, tourism, leisure and entertainment comprehensive consumption. The Company operates its businesses through four segments. The Commercial segment is principally engaged in department store retail. The Pharmaceutical Industry segment is mainly engaged in the sales of various types of chinese medicinal materials, chinese patent medicines, western medicines, ginseng and antler supplements, nutritional health products and medical equipment. The Hotel Services segment is principally engaged in the operation of Radisson brand hotels managed by Radisson Hotel Group. The Company is also engaged in other businesses segment. The Company mainly operates its businesses in the domestic market.

Sector

Pharmaceuticals

Calendar

28/06/2024 - Annual General Meeting

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
SHANGHAI NEW WORLD CO., LTD	-17.40%	52Cr
ELI LILLY AND COMPANY	+45.82%	77TCr
JOHNSON & JOHNSON	-6.16%	35TCr
MERCK & CO., INC.	+19.86%	33TCr
ABBVIE INC.	+9.32%	30TCr
ASTRAZENECA PLC	+18.79%	25TCr
ROCHE HOLDING AG	-1.39%	22TCr
NOVARTIS AG	+10.97%	22TCr
AMGEN INC.	+5.90%	16TCr
PFIZER, INC.	-0.73%	16TCr